Page last updated: 2024-11-01

ofloxacin and ALS - Amyotrophic Lateral Sclerosis

ofloxacin has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Salado, IG1
Redondo, M1
Bello, ML1
Perez, C1
Liachko, NF1
Kraemer, BC1
Miguel, L1
Lecourtois, M1
Gil, C2
Martinez, A2
Perez, DI1
Nozal, V1
Martínez-González, L1
Gomez-Almeria, M1
Gonzalo-Consuegra, C1
Santana, P1
Chaikuad, A1
Pérez-Cuevas, E1
Knapp, S1
Lietha, D1
Ramírez, D1
Petralla, S1
Monti, B1
Martín-Requero, A1
Palomo, V1
de Lago, E1

Other Studies

2 other studies available for ofloxacin and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis.
    Journal of medicinal chemistry, 2014, Mar-27, Volume: 57, Issue:6

    Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Benzothiazoles; Blood-Brain B

2014
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Animals; Brain; Case-Control Studies; DNA-Binding Proteins; Humans; I

2022